Loading paragraph...
Today's Biggest Stock Gainers
| Symbol | Name | Last Price | Change | % Change | Volume | Market Cap | 52-Week Range |
|---|---|---|---|---|---|---|---|
| EKSO | Ekso Bionics | $9.97 | $4.51 | 82.68% | 48.6M | $19M | $2.73$14.97 |
| AEHL | Antelope Enterprise | $2.03 | $0.90 | 79.50% | 35.3M | $3.9M | $1.01$11.53 |
| CETX | Cemtrex | $3.26 | $1.15 | 54.50% | 55M | $15M | $2.10$55.50 |
| ONTF | ON24 | $8.01 | $2.15 | 36.60% | 1.8M | $248M | $4.35$8.02 |
| FLYE | Fly-E Group | $7.17 | $1.89 | 35.69% | 2.9M | $8.6M | $3.83$166.00 |
| DRMA | Dermata Therapeutics | $2.49 | $0.63 | 33.87% | 19.2M | $1.9M | $1.58$23.70 |
| BRLS | Borealis Foods | $2.08 | $0.47 | 29.00% | 223.1K | $35M | $1.51$7.49 |
| FONR | Fonar | $18.77 | $4.11 | 28.04% | 784.3K | $93M | $12.00$18.86 |
| ULY | Urgent.ly | $2.23 | $0.42 | 23.20% | 4.8K | $4.0M | $1.74$17.99 |
| AFJK | Aimei Health Technology | $53.34 | $9.69 | 22.20% | 87.8K | $267M | $6.75$98.15 |
Related Articles
Featured Article
1 Drug, 1 Mission: What Should Investors Expect for Greenwich Life Sciences?
Jia Jie Chen|Apr 21, 2021
The top-performing IPO of 2020 is a high-risk, high-reward opportunity, with one drug in its pipeline and one disease in its sights. Is it worth investing in now?
This Was the Top-Performing IPO in 2020
Rick Munarriz|Dec 28, 2020
A lot of buzz-generating IPOs have more than tripled in 2020, but you probably don't know the top U.S. debutante that has soared 583% this year.
Up 1,600% In 2 Days, Is It Too Late To Buy This Hot Biotech Stock?
Zhiyuan Sun|Dec 10, 2020
Greenwich LifeSciences made investors rich overnight. Is there any growth left in this breast cancer treatment developer?
Advertisement
Risks Rise for Studio City International as Macau Gaming Market Slows
Rich Duprey|Dec 1, 2018
Like much of Macau, its future hinges on VIP gamblers.
3 Top Stocks Under $5
Maxx Chatsko|Dec 4, 2017
Investors may want to put Idera Pharmaceuticals, Yamana Gold, and Ekso Bionics on their watchlists.
